Sensus Healthcare Inc.

NASDAQ: SRTS · Real-Time Price · USD
4.82
0.01 (0.21%)
At close: Jun 16, 2025, 3:59 PM
4.99
3.53%
After-hours: Jun 16, 2025, 07:28 PM EDT

Company Description

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices.

It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.

The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services.

In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body.

Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare Inc.
Sensus Healthcare Inc. logo
Country United States
IPO Date Jul 26, 2016
Industry Medical - Devices
Sector Healthcare
Employees 54
CEO Joseph C. Sardano

Contact Details

Address:
851 Broken Sound Parkway NW
Boca Raton, Florida
United States
Website https://www.sensushealthcare.com

Stock Details

Ticker Symbol SRTS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001494891
CUSIP Number 81728J109
ISIN Number US81728J1097
Employer ID 27-1647271
SIC Code 3841

Key Executives

Name Position
Joseph C. Sardano Co-Founder, Chairman & Chief Executive Officer
Emiliano Sosa Chief Technology Officer
Javier Rampolla Chief Financial Officer
Magdalena Martinez Chief Operating Officer
Michael J. Sardano J.D. President, General Counsel, Corporate Secretary & Director
Stephanie Tipton Vice President of Marketing

Latest SEC Filings

Date Type Title
Jun 10, 2025 3 Filing
Jun 02, 2025 8-K Current Report
May 30, 2025 SD Filing
May 22, 2025 SCHEDULE 13G/A [Amend] Filing
May 15, 2025 10-Q Quarterly Report
May 15, 2025 8-K Current Report
Apr 29, 2025 DEF 14A Filing
Mar 05, 2025 10-K Annual Report
Feb 11, 2025 8-K Current Report
Feb 10, 2025 4 Filing